ResearcherSeoul National UniversityActive in the last 2 years
Jin‐Young Jang
Matched on OpenAlex author ID A5112022069. Sources: OpenAlex.
Their work
- Papers
- 15 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 69
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 8 papers · 2024: 2 papers · 2025: 2 papers · 2026: 1 paper
Papers 15
- Non-thermal focused ultrasound with FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer: An explorative phase II trial. Last author DOI 10.1016/j.ejca.2026.116903↗
- The FOXP1-ABCG2 axis promotes the proliferation of cancer stem cells and induces chemoresistance in pancreatic cancer. Co-author DOI 10.1038/s41417-025-00896-7↗
- SLC5A3 depletion promotes apoptosis by inducing mitochondrial dysfunction and mitophagy in gemcitabine-resistant pancreatic cancer cells. Co-author DOI 10.1038/s41419-025-07476-5↗
- Defining and tracing subtypes of patient-derived xenograft models in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/cac2.12585↗
- Development of a Fit-For-Purpose Multi-Marker Panel for Early Diagnosis of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.mcpro.2024.100824↗
- Lysosomal Storage Dysfunction, a Germline Variants Affecting Pancreatic Ductal Adenocarcinoma Development and Progression Co-author DOI 10.1101/2023.02.15.23286007↗
- FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analy… Co-author DOI 10.1245/s10434-023-13353-2↗
- Whole exome sequencing and RNA sequencing analyses of PDAC samples Co-author DOI 10.21203/rs.3.pex-2062/v1↗
- Mass spectrometry-based proteomic analysis of PDAC samples Co-author DOI 10.21203/rs.3.pex-2063/v1↗
- Bioinformatics analysis of PDAC subtypes Co-author DOI 10.21203/rs.3.pex-2064/v1↗
- Cell-based assays for potential prognostic biomarkers in PDAC Co-author DOI 10.21203/rs.3.pex-2065/v1↗
- Assays for orthotopic PDAC mouse models Co-author DOI 10.21203/rs.3.pex-2066/v1↗
- Lysosomal Storage Dysfunction, a Germline Variants Affecting Pancreatic Ductal Adenocarcinoma Development and Progression Co-author DOI 10.21203/rs.3.rs-2578124/v1↗
- Pancreatic adenocarcinoma with atypical imaging features mimicking chronic pancreatitis in a dog. Co-author DOI 10.17221/132/2021-vetmed↗
- Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value. Last author DOI 10.1111/jgh.13253↗
Closest collaborators
The 25 strongest of 69 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wooil Kwon · 11 shared papers, 2016–2026 · strength 1.83
- Paper Non-thermal focused ultrasound with FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer: An expl… DOI 10.1016/j.ejca.2026.116903↗
- Paper The FOXP1-ABCG2 axis promotes the proliferation of cancer stem cells and induces chemoresistance in pancreatic cancer. DOI 10.1038/s41417-025-00896-7↗
- Paper SLC5A3 depletion promotes apoptosis by inducing mitochondrial dysfunction and mitophagy in gemcitabine-resistant pancre… DOI 10.1038/s41419-025-07476-5↗
- Daechan Park · 8 shared papers, 2023–2024 · strength 1.07
- Paper Defining and tracing subtypes of patient-derived xenograft models in pancreatic ductal adenocarcinoma. DOI 10.1002/cac2.12585↗
- Paper Lysosomal Storage Dysfunction, a Germline Variants Affecting Pancreatic Ductal Adenocarcinoma Development and Progressi… DOI 10.1101/2023.02.15.23286007↗
- Paper Lysosomal Storage Dysfunction, a Germline Variants Affecting Pancreatic Ductal Adenocarcinoma Development and Progressi… DOI 10.21203/rs.3.rs-2578124/v1↗
- Sangyeop Hyun · 6 shared papers, 2023–2024 · strength 0.79
- Paper Defining and tracing subtypes of patient-derived xenograft models in pancreatic ductal adenocarcinoma. DOI 10.1002/cac2.12585↗
- Paper Whole exome sequencing and RNA sequencing analyses of PDAC samples DOI 10.21203/rs.3.pex-2062/v1↗
- Paper Mass spectrometry-based proteomic analysis of PDAC samples DOI 10.21203/rs.3.pex-2063/v1↗
- Ja‐Lok Ku · 6 shared papers, 2023–2024 · strength 0.79
- Paper Defining and tracing subtypes of patient-derived xenograft models in pancreatic ductal adenocarcinoma. DOI 10.1002/cac2.12585↗
- Paper Whole exome sequencing and RNA sequencing analyses of PDAC samples DOI 10.21203/rs.3.pex-2062/v1↗
- Paper Mass spectrometry-based proteomic analysis of PDAC samples DOI 10.21203/rs.3.pex-2063/v1↗
- Hongbeom Kim · 6 shared papers, 2023 · strength 0.71
- Paper FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-… DOI 10.1245/s10434-023-13353-2↗
- Paper Whole exome sequencing and RNA sequencing analyses of PDAC samples DOI 10.21203/rs.3.pex-2062/v1↗
- Paper Mass spectrometry-based proteomic analysis of PDAC samples DOI 10.21203/rs.3.pex-2063/v1↗
- Hye‐Sol Jung · 3 shared papers, 2024–2025 · strength 0.66
- Paper The FOXP1-ABCG2 axis promotes the proliferation of cancer stem cells and induces chemoresistance in pancreatic cancer. DOI 10.1038/s41417-025-00896-7↗
- Paper SLC5A3 depletion promotes apoptosis by inducing mitochondrial dysfunction and mitophagy in gemcitabine-resistant pancre… DOI 10.1038/s41419-025-07476-5↗
- Paper Development of a Fit-For-Purpose Multi-Marker Panel for Early Diagnosis of Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.mcpro.2024.100824↗
- Taesung Park · 6 shared papers, 2016–2023 · strength 0.65
- Min‐Sik Kim · 5 shared papers, 2023 · strength 0.59
- Sung Hee Baek · 5 shared papers, 2023 · strength 0.59
- Keehoon Jung · 5 shared papers, 2023 · strength 0.59
- Sang‐Won Lee · 5 shared papers, 2023 · strength 0.59
- Do Young Hyeon · 5 shared papers, 2023 · strength 0.59
- Duk Ki Kim · 5 shared papers, 2023 · strength 0.59
- Gibeom Kim · 5 shared papers, 2023 · strength 0.59
- Joon Seong Park · 2 shared papers, 2025 · strength 0.48
- Paper The FOXP1-ABCG2 axis promotes the proliferation of cancer stem cells and induces chemoresistance in pancreatic cancer. DOI 10.1038/s41417-025-00896-7↗
- Paper SLC5A3 depletion promotes apoptosis by inducing mitochondrial dysfunction and mitophagy in gemcitabine-resistant pancre… DOI 10.1038/s41419-025-07476-5↗
- Hyeon Woong Kang · 2 shared papers, 2025 · strength 0.48
- Paper The FOXP1-ABCG2 axis promotes the proliferation of cancer stem cells and induces chemoresistance in pancreatic cancer. DOI 10.1038/s41417-025-00896-7↗
- Paper SLC5A3 depletion promotes apoptosis by inducing mitochondrial dysfunction and mitophagy in gemcitabine-resistant pancre… DOI 10.1038/s41419-025-07476-5↗
- Woosol Chris Hong · 2 shared papers, 2025 · strength 0.48
- Paper The FOXP1-ABCG2 axis promotes the proliferation of cancer stem cells and induces chemoresistance in pancreatic cancer. DOI 10.1038/s41417-025-00896-7↗
- Paper SLC5A3 depletion promotes apoptosis by inducing mitochondrial dysfunction and mitophagy in gemcitabine-resistant pancre… DOI 10.1038/s41419-025-07476-5↗
- Minsoo Kim · 2 shared papers, 2025 · strength 0.48
- Paper The FOXP1-ABCG2 axis promotes the proliferation of cancer stem cells and induces chemoresistance in pancreatic cancer. DOI 10.1038/s41417-025-00896-7↗
- Paper SLC5A3 depletion promotes apoptosis by inducing mitochondrial dysfunction and mitophagy in gemcitabine-resistant pancre… DOI 10.1038/s41419-025-07476-5↗
- Won‐Gun Yun · 2 shared papers, 2024 · strength 0.38
- Dong Ho Lee · 1 shared paper, 2026 · strength 0.32
- Jae Young Lee · 1 shared paper, 2026 · strength 0.32
- Woo Hyun Paik · 1 shared paper, 2026 · strength 0.32
- In Rae Cho · 1 shared paper, 2026 · strength 0.32
- Sang Hyub Lee · 1 shared paper, 2026 · strength 0.32
- Jong Kyun Lee · 2 shared papers, 2023 · strength 0.28
- Paper Lysosomal Storage Dysfunction, a Germline Variants Affecting Pancreatic Ductal Adenocarcinoma Development and Progressi… DOI 10.1101/2023.02.15.23286007↗
- Paper Lysosomal Storage Dysfunction, a Germline Variants Affecting Pancreatic Ductal Adenocarcinoma Development and Progressi… DOI 10.21203/rs.3.rs-2578124/v1↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.